Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial stress induction in tumor cells refers to the deliberate triggering or enhancement of mitochondrial dysfunction and associated stress responses within cancer cells. This process exploits the unique metabolic and signaling dependencies of tumor mitochondria, aiming to disrupt their adaptive mechanisms, promote cell death, or sensitize tumors to therapy.
Induction of unresolvable mitochondrial dysfunction, blocking adaptive stress responses, disrupting energy production, promoting ROS accumulation, activating apoptosis
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Stress Induction in Tumor Cells (MSR Induction).